Four years intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

被引：0
|
作者：
Lamy, O [1 ]
Sandini, L [1 ]
Burnand, J [1 ]
Krieg, MA [1 ]
Burckhardt, P [1 ]
机构：
[1] Univ Lausanne Hosp, Lausanne, Switzerland
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
491
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [1] Intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Thiebaud, D
    Kriegbaum, H
    Huss, H
    Christiansen, C
    Burckhardt, P
    OSTEOPOROSIS 1996, 1996, 1118 : 321 - 325
  • [2] Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Thiebaud, D
    Burckhardt, P
    Kriegbaum, H
    Huss, H
    Juttmann, JR
    Schoter, KH
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (04): : 298 - 307
  • [3] Tri-monthly intravenous injections of ibandronate for treatment of postmenopausal osteoporosis
    Brenner, K
    Loho, N
    Mirzai, S
    Keck, AV
    Hoyle, N
    Felsenberg, D
    Pecherstorfer, M
    BONE, 2002, 30 (03) : 47S - 47S
  • [4] Two years intravenous injections of ibandronate in the treatment of osteoporosis in men
    Lamy, O
    Sandini, L
    Burnand, J
    Krieg, MA
    Burckhardt, P
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S188 - S188
  • [5] Rationale for intermittent intravenous Ibandronate injections in postmenopausal osteoporosis.
    Miller, PD
    Recker, RR
    Adami, S
    Bonvoisin, B
    Schimmer, RC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S263 - S263
  • [6] Intravenous Ibandronate injections and oral Ibandronate: Favorable renal tolerability profile in postmenopausal osteoporosis.
    Miller, Paul D.
    Ward, Penelope
    Leigh, Christine
    Burdeska, Alexander
    Recker, Robert R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S583 - S584
  • [7] Quarterly intravenous ibandronate for postmenopausal osteoporosis
    Emkey, Ronald D.
    WOMENS HEALTH, 2008, 4 (03) : 219 - 228
  • [8] Intravenous ibandronate injections for osteoporosis treatment in children with rheumatic diseases
    Lisitsin, Alexander
    Ekaterina, Alexeeva
    Alexander, Lisitsin
    Saniya, Valieva
    Tatyana, Bzarova
    Rina, Denisova
    Alexandra, Chomahidze
    Kseniya, Isayeva
    Evgenia, Chistyakova
    Anatoliy, Anikin
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 441 - 441
  • [9] Tri-monthly intravenous injections of ibandronate (2mg) for treatment of postmenopausal osteoporosis.
    Pecherstorfer, M
    Loho, N
    Mirzai, S
    Brenner, K
    Hoyle, N
    Felsenberg, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S406 - S406
  • [10] Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis
    Recker, R
    Stakkestad, JA
    Chesnut, CH
    Christiansen, C
    Skag, A
    Hoiseth, A
    Ettinger, M
    Mahoney, P
    Schimmer, RC
    Delmas, DP
    BONE, 2004, 34 (05) : 890 - 899
12345